TIGIT and autoimmune disease: Different strategies such as TIGIT overexpression, agonistic anti-TIGIT mAb, recombinant CD155 protein, and TIGIT-Ig fusion protein have been used in mice models for treatment of autoimmune diseases (Table 2).